Clinical trial
Determine Long-Term Safety and Tolerability of Pregabalin in Patients With…
NCT00150449 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00150449 |
|---|---|
| Title | Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders. |
| Official title | A 1-Year Open-Label Safety Extension Study of Pregabalin in Patients With Anxiety Disorders |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anxiety Neuroses |
| Intervention type | Drug |
| Interventions | Pregabalin |
| Enrollment | 511 |
| Start date | Jan 1, 2001 |
| Completion | Mar 1, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | Jul 14, 2006 |
| Countries | Austria, Belgium, Estonia, France, Germany, Israel, Italy, Latvia, Netherlands, Poland, South Africa, Spain and 2 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: